查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1893645

全球切片检查设备市场

Biopsy Devices
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球切片检查设备市场预计到2030年将达到59亿美元。

2024年全球切片检查设备市场规模预估为45亿美元，预计2030年将达59亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为4.5%。本报告分析的细分市场之一－医院终端用户市场，预计复合年增长率为4.7%，到分析期末将达到45亿美元。诊断中心终端用户市场预计在分析期间内复合年增长率为3.9%。

美国市场规模估计为12亿美元，而中国市场预计将以4.2%的复合年增长率成长。

预计到2024年，美国切片检查设备市场规模将达12亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到9.272亿美元，在2024年至2030年的分析期内，年复合成长率（CAGR）为4.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的年复合成长率分别为4.4%和3.2%。在欧洲，德国的年复合成长率预计约为3.8%。

全球切片检查设备市场—主要趋势和驱动因素摘要

切片检查设备为何备受关注

切片检查设备是诊断流程的基石，尤其是在各种癌症的早期检测和后续观察中。近年来，切片检查设备的技术进步显着提高了其准确性、安全性和患者舒适度。从传统的针刺活检到先进的影像引导和机器人辅助技术，这些设备经历了巨大的发展。这些创新不仅提高了组织采集的准确性，而且最大限度地减少了手术的侵入性，从而缩短了恢復时间并减少了併发症。切片检查设备与超音波、磁振造影（MRI）和电脑断层扫描）等影像技术的结合，进一步革新了该领域。这使得手术过程中能够进行即时引导，并确保从最相关的区域获取样本，从而提高诊断准确性。

终端用户趋势如何影响切片检查设备市场？

受医疗保健行业终端用户趋势变化的驱动，切片检查设备的使用方式发生了显着转变。癌症和其他慢性疾病发生率的上升推动了对早期精准诊断工具的需求。虽然医院和诊断中心是切片检查设备的主要用户，但门诊诊所和专科癌症中心也越来越多地采用这些技术。这种转变主要源自于人们对早期检测和个人化医疗的日益重视，而这需要精准快速的诊断。此外，全球人口老化以及人们对定期体检重要性的认识不断提高，也推动了对常规切片检查的需求。这一趋势在医疗基础设施完善、能够支援先进诊断技术的已开发地区尤其明显，但新兴市场也在迅速迎头赶上，进一步推动了对这些设备的需求。

哪些创新将塑造切片检查设备的未来？

切片检查设备的未来发展正受到持续创新成果的影响，这些创新旨在改善患者预后并提高诊断准确性。其中一个最重要的进展是液态生物检体的出现，它是一种微创的替代传统切片检查的方法。液态生物检体分析血液样本中的循环性肿瘤细胞和DNA，无需手术即可提供有关癌症存在和进展的重要资讯。另一项创新是开发一次性切片检查设备，以降低交叉污染和感染的风险。这些设备在对无菌环境要求极高的场所特别有用。此外，机器人切片检查技术的进步正在提高检体采集的准确性和一致性，减少人为误差，并简化更复杂的操作。这些创新不仅提高了切片检查的效率，还扩大了可透过切片检查诊断的疾病范围。

哪些因素正在推动切片检查设备市场的成长？

切片检查设备市场的成长受多种因素驱动。癌症和其他慢性疾病的日益普遍导致对早期准确诊断的迫切需求，这是推动市场成长的主要动力之一。影像技术的融合和微创切片检查技术的开发等技术进步显着提高了切片检查的准确性和安全性，使其更易于患者接受。此外，个人化医疗的趋势也推动了对精准诊断工具的需求，因为治疗方案越来越注重个别疾病特征的客製化。同时，新兴市场医疗基础设施的不断改进也为先进切片检查设备的应用创造了机会。政府对癌症研究和早期诊断项目的投入和支持也在促进市场成长方面发挥关键作用。随着人们对早期检测重要性的认识不断提高，在技术创新和全球医疗实践变革的双重推动下，预计切片检查设备市场将保持持续增长的需求。

部分：

影像技术（超音波导引切片检查、 电脑断层扫描扫描导引切片检查、MRI引导切片检查、立体定位引导切片检查、其他影像技术）、最终用途（医院、诊断中心）

受访公司范例

  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group, Inc.
  • FUJIFILM Holdings Corporation
  • Hologic, Inc.
  • Inrad, Inc.
  • Medtronic PLC
  • Olympus Corporation

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，改变您分析市场和竞争情报的方式。

Market Glass, Inc. 并没有采用查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括视频转录、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在地、製造地以及进出口（成品和OEM产品）情况，预测企业竞争地位的变化。这种复杂多变的市场现实将对竞争对手产生许多影响，包括销货成本增加、盈利下降以及供应链重组。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP10731

Global Biopsy Devices Market to Reach US$5.9 Billion by 2030

The global market for Biopsy Devices estimated at US$4.5 Billion in the year 2024, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$4.5 Billion by the end of the analysis period. Growth in the Diagnostics Centers End-Use segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 4.2% CAGR

The Biopsy Devices market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$927.2 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Biopsy Devices Market - Key Trends and Drivers Summarized

Why Are Biopsy Devices Gaining Attention?

Biopsy devices have become a cornerstone in the diagnostic process, particularly in the early detection and monitoring of various cancers. Recent technological advancements in biopsy devices have significantly improved their accuracy, safety, and patient comfort. From traditional needle biopsies to advanced image-guided and robotic-assisted techniques, the evolution of these devices is remarkable. These innovations have not only enhanced the precision of tissue sampling but also minimized the invasiveness of the procedure, leading to quicker recovery times and fewer complications. The integration of imaging technologies like ultrasound, MRI, and CT scans with biopsy devices has further revolutionized the field, enabling real-time guidance during the procedure and ensuring that the samples collected are from the most relevant areas, thereby increasing diagnostic accuracy.

How Are End-Use Trends Shaping the Biopsy Devices Market?

The utilization of biopsy devices is seeing a notable shift, driven by changes in end-use trends within the healthcare sector. With the rising incidence of cancer and other chronic diseases, there is an increasing demand for early and accurate diagnostic tools. Hospitals and diagnostic centers are the primary users of biopsy devices, but there’s a growing trend of outpatient clinics and specialized cancer centers adopting these technologies. This shift is largely due to the emphasis on early detection and personalized medicine, which requires precise and timely diagnosis. Moreover, the aging global population, coupled with the growing awareness of regular health check-ups, is driving the demand for routine biopsy procedures. This trend is particularly noticeable in developed regions, where healthcare infrastructure supports advanced diagnostic practices, but emerging markets are quickly catching up, further fueling the demand for these devices.

What Innovations Are Shaping the Future of Biopsy Devices?

The future of biopsy devices is being shaped by continuous innovations aimed at improving patient outcomes and diagnostic accuracy. One of the most significant developments is the advent of liquid biopsies, which offer a less invasive alternative to traditional tissue biopsies. Liquid biopsies analyze circulating tumor cells or DNA from a blood sample, providing crucial information about the presence and progression of cancer without the need for surgery. Another area of innovation is the development of single-use, disposable biopsy devices that reduce the risk of cross-contamination and infection. These devices are particularly valuable in settings where sterility is a top priority. Additionally, advancements in robotic-assisted biopsy procedures are enhancing the precision and consistency of sample collection, reducing human error, and enabling more complex procedures to be performed with greater ease. These innovations are not only improving the efficiency of the biopsy process but are also expanding the range of conditions that can be diagnosed through biopsy.

What’s Driving the Growth in the Biopsy Devices Market?

The growth in the biopsy devices market is driven by several factors. The rising prevalence of cancer and other chronic diseases has led to an urgent need for early and accurate diagnosis, which is one of the primary drivers of market growth. Technological advancements, such as the integration of imaging technologies and the development of less invasive biopsy techniques, have significantly improved the accuracy and safety of biopsies, making them more accessible and acceptable to patients. Additionally, the trend toward personalized medicine is fueling demand for precise diagnostic tools, as treatments are increasingly tailored to the specific characteristics of an individual’s disease. Moreover, the expansion of healthcare infrastructure in emerging markets is creating new opportunities for the adoption of advanced biopsy devices. Government initiatives and funding for cancer research and early diagnosis programs are also playing a crucial role in supporting market growth. As awareness of the importance of early detection continues to grow, the biopsy devices market is expected to experience sustained demand, driven by both technological innovations and shifts in healthcare practices globally.

SCOPE OF STUDY:

The report analyzes the Biopsy Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Imaging Technology (Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy, Other Imaging Technologies); End-Use (Hospitals, Diagnostics Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group, Inc.
  • FUJIFILM Holdings Corporation
  • Hologic, Inc.
  • Inrad, Inc.
  • Medtronic PLC
  • Olympus Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Biopsy Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Imaging Technologies Propel Growth of Biopsy Devices Market
    • Rising Prevalence of Cancer Spurs Demand for Innovative Biopsy Solutions
    • Emerging Liquid Biopsy Techniques Expand Addressable Market Opportunity
    • Growing Preference for Minimally Invasive Procedures Strengthens Business Case for Biopsy Devices
    • Integration of AI and Machine Learning in Diagnostics Generates Demand for Enhanced Biopsy Devices
    • Aging Population and Increased Cancer Screening Programs Sustain Market Growth
    • Focus on Early Detection Solutions Propels Market Expansion
    • Innovations in Needle Design and Tissue Sampling Methods Drive Product Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Ultrasound-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Ultrasound-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Ultrasound-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for CT Scan-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for CT Scan-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for CT Scan-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for MRI-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for MRI-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for MRI-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Steretactics-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Steretactics-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Steretactics-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Imaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Imaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Other Imaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Diagnostics Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Biopsy Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Biopsy Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Biopsy Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2015, 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2015, 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of World 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2015, 2025 & 2030

IV. COMPETITION